Related Experiment Video
Updated: Feb 13, 2026

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
Otoacoustic emissions in children treated with gentamicin in a secondary hospital
Jose Miguel Sequi Canet1, Carlos Miguel Angelats Romero1, Jose Miguel Sequi Sabater1
1Servicio de Pediatría, Hospital Francesc de Borja, Gandia, Valencia, España.
Insights
Gentamicin is safe for children when used for less than 10 days. Evoked otoacoustic emissions (EOAE) effectively monitor for hearing loss from gentamicin ototoxicity.
Area of Science:
- Pediatrics
- Otolaryngology
- Pharmacology
Background:
- The National Commission for the Early Detection of Hearing Loss (CODEPEH) advises hearing re-evaluation after exposure to ototoxic drugs like gentamicin.
- Evoked otoacoustic emissions (EOAE) are a valuable tool for assessing cochlear function.
Purpose of the Study:
- To evaluate the ototoxicity of gentamicin in children.
- To assess the utility of EOAE in monitoring gentamicin's effects on hearing.
Main Methods:
- A prospective study involved 92 children treated with intravenous gentamicin.
- Serial EOAE measurements were taken: on admission, at treatment completion, and one month post-treatment.
Main Results:
- No children in the study experienced hearing impairment due to gentamicin treatment.
- The study found no ototoxic effects from gentamicin under the specified conditions.
Conclusions:
- Gentamicin appears safe for pediatric use in treatments under 10 days at described doses.
- EOAE provide a reliable, non-invasive method for detecting gentamicin-induced ototoxicity, potentially reducing the need for drug level monitoring.
Introduction:
The National Commission for the Early Detection of Hearing Loss (CODEPEH) recommends the re-evaluation of hearing in children who have suffered any potentially harmful event, such as the prescription of ototoxic antibiotics such as gentamicin. The evoked otoacoustic emissions (EOAE) are a good method for assessing the integrity of cochlear functionality.
Material And Method:
A prospective study is presented, including 92 children who were treated with intravenous gentamicin for septic risk/sepsis or urinary tract infection. The children underwent serial EOAE: on admission, at the end of treatment and one month later (if altered on discharge).
Results:
In the end, none of the subjects were affected by the treatment.
Conclusion:
Gentamicin appears to be a safe antibiotic in treatments lasting <10days and at the doses described. EOAE are an inexpensive, fast, non-invasive and reliable method to check for gentamicin ototoxicity. This could save in the determination of drug levels.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Emission Spectra
Secondary Active Transport
Secondary Active Transport
Secondary Healthcare System

